vidarabine has been researched along with Benign Monoclonal Gammopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhry, HM; Mauermann, ML; Rajkumar, SV | 1 |
| Bhattacharyya, J; Kimura, A; Mihara, K; Takihara, Y | 1 |
1 review(s) available for vidarabine and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.
Topics: Administration, Intravenous; Biomarkers; Demyelinating Autoimmune Diseases, CNS; Diagnosis, Differential; Glycoproteins; Humans; Immunoglobulins; Immunologic Factors; Monoclonal Gammopathy of Undetermined Significance; Myeloablative Agonists; Peripheral Nervous System Diseases; Plasmapheresis; Prognosis; Rituximab; Vidarabine | 2017 |
1 other study(ies) available for vidarabine and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cryoglobulinemia; Cyclophosphamide; Female; Humans; Immunoglobulin M; Livedo Reticularis; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Rituximab; Vidarabine | 2012 |